Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index
NCT00879944 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 409
Last updated 2015-04-14
Summary
The object of this research study is to examine these associations in children as very little is known about psoriasis and cardiovascular risk factors in the pediatric population.
Conditions
Interventions
- OTHER
-
Blood pressure
Blood pressure will be measured once while patient is seated
- OTHER
-
Height
Height will be measured in centimeters at the time of enrollment
- OTHER
-
Weight
Weight will be measured in kilograms at enrollment
- OTHER
-
BMI
Body Mass Index (BMI) will be calculated from a subject's height and weight
- OTHER
-
Waist Circumference
Waist circumference will be measured midway between the lowest rib and the superior border of the iliac crest with an inelastic measuring tape at the end of normal expiration to the nearest 0.1cm
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Amy S Paller, MD · Northwestern University
Eligibility
- Min Age
- 5 Years
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-05-31
- Primary Completion
- 2012-06-30
- Completion
- 2012-07-31
Countries
- United States
- Canada
- Chile
- Hong Kong
- Italy
- Netherlands
Study Locations
More Related Trials
-
Modified Intermittent Fasting in Psoriasis
NCT04418791 ·Status: COMPLETED ·Phase: NA
-
A Single-Center, Prospective, Pilot Study to Compare the Effect of Diet in Overweight or Obese Patients With Psoriasis on Light Therapy
NCT02193919 ·Status: COMPLETED
-
Peds Metabolic Syndrome in Psoriasis
NCT00930592 ·Status: COMPLETED
-
A Case Control Study Evaluating the Prevalence of Non-Alcoholic Fatty Liver Disease Among Patients With Psoriasis
NCT00930384 ·Status: COMPLETED
-
Weight Reduction Alone May Not be Sufficient to Maintain Disease Remission in Obese Patients With Psoriasis
NCT01439425 ·Status: UNKNOWN ·Phase: PHASE4
-
Comparative Analysis of Small and Large Plaque Psoriasis
NCT01920906 ·Status: COMPLETED ·Phase: NA
-
Patients With Hidradenitis vs Patients With Psoriasis: Psychological Impact
NCT02999698 ·Status: UNKNOWN
-
Safety and Efficacy of IDP-122 in the Treatment of Participants With Plaque Psoriasis
NCT02514577 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy Study of Dietary Intervention and Weight Loss in Improving Psoriasis
NCT01714284 ·Status: COMPLETED ·Phase: NA
-
Developing A Validated Measure of the Impact of Psoriasis on Chronic Quality of Life
NCT00823914 ·Status: COMPLETED
-
Safety and Efficacy of IDP-122 in the Treatment of Participants With Plaque Psoriasis
NCT02515097 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating The Safety And Tolerability Of ILV-094 In Subjects With Psoriasis
NCT00563524 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis
NCT03701763 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Effect of Diet in Overweight or Obese Patients With Psoriasis on Light Therapy
NCT00537212 ·Status: COMPLETED ·Phase: NA
-
Effects of TNF-alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and Psoriasis
NCT00477191 ·Status: TERMINATED ·Phase: NA
-
Clinical Assessment and Psychosocial Impact of Psoriasis
NCT01964443 ·Status: COMPLETED
-
Psoriasis Inflammation and Systemic Co Morbidities
NCT01170715 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis
NCT01194219 ·Status: COMPLETED ·Phase: PHASE3
-
Thalidomide in the Treatment of Chronic Plaque Psoriasis.
NCT01891019 ·Status: COMPLETED ·Phase: PHASE2
-
Physician- vs Questionnaire-Based Screening for Psoriatic Arthritis in Psoriasis
NCT07298265 ·Status: RECRUITING
-
Pediatric Open-Label Extension Study of Etanercept in Patients With Plaque Psoriasis
NCT00141921 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Clinical Outcomes in an Online Teledermatology Model for the Management of Psoriasis
NCT00971477 ·Status: COMPLETED ·Phase: PHASE2
-
Combining Topical Corticosteroid and LCD Treatment for Localized Plaque Psoriasis
NCT00769184 ·Status: COMPLETED ·Phase: NA
-
A Phase 3 Study in Moderate-to-Severe Plaque Psoriasis With Piclidenoson to Study Safety and Efficacy
NCT06643260 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Therapeutic Education Program in Psoriasis
NCT02310204 ·Status: COMPLETED ·Phase: NA